Infection risk

Published on 03/06/2015 by admin

Filed under Neonatal - Perinatal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1456 times

CHAPTER 17 Infection risk

Antibiotic use

There is no magic formula that tells us which babies must be treated with antibiotics.

For suspected late-onset or nosocomial infection (appearing >48 hours after nursery admission)

Late-onset infection can present in many ways (including signs common in babies without infection), therefore any concerns about an infant should prompt the question: Could this be due to infection? Always err on the side of taking cultures and starting antibiotics.

Common signs include:

The basic principle is to cover:

Under some circumstances broader coverage is justified. This may include cover for anaerobes or fungi. Some justify the empirical use of vancomycin on the grounds that most of their infecting organisms are coagulase-negative staphylococci. However, using too much vancomycin will one day lead to the emergence of vancomycin-resistant organisms.

Prevention of neonatal early-onset GBS disease (EOGBSD)

The prevention of early-onset GBS disease requires strategies for both the mother and the baby.

There are two obstetric approaches:

The neonatal approach is outlined below.

Queensland approach

Following consideration of all available information and in the light of the current low rate (0.39/1000 births) of EOGBSD in Queensland in 2002, the Perinatal Clinical Practice Guidelines Working Party on Early Onset Group B Streptococcal Disease and Prelabour Rupture of the Membranes at Term (coordinated by the Centre for Clinical Studies, Mater Hospital, South Brisbane and the Southern Zone Maternal Neonatal and Gynaecology Network, Southern Zone Management Unit) reached a consensus to continue to recommend the modified risk factor approach.

They have produced the Clinical Practice Guidelines for the prevention of neonatal early-onset group B streptococcal disease (EOGBSD) for Queensland hospitals.

Our suggested approach in light of these guidelines is: